Cerulean Pharma’s nanopharmaceuticals: From bench to bedside

Scott Eliasof

Scott Eliasof

Vice President of Research

Cerulean Pharma Inc.

Scott is vice president of research at Cerulean Pharma Inc. Previously, he was the director of the Chemical Biology Platform at the Broad Institute, directing a multi-disciplinary team of professional scientists and technicians in the fields of synthetic chemistry, analytical chemistry, high-throughput screening, computational science, and software engineering. This interdisciplinary organization is closely affiliated with the laboratory of Stuart Schreiber from Harvard University and is one of the largest and oldest academic screening centers in the country. Prior to joining the Broad Institute, Scott worked at Millennium Pharmaceuticals, where he managed scientific teams in cell biology, molecular biology, neuroscience, and bioinformatics for a large-scale genomics-based drug discovery program. Earlier in his career, Scott was at Neurocrine Biosciences, where he played a key role in the exploration of glutamate transporters in the field of stroke and neurological disorders.

Sponsor & Exhibitor Opportunities

 Exhibit and Showcase
 Become a Sponsor

Please contact: Denise Lee


TechConnect Acceleration Partners:

BASF
BayerMaterialScience
Battelle
Bosch
bp
DOW
GE
Honda
Hyundai
Ingersoll Rand
intel
Lockheed Martin
MWV
Merck
novaris
Panasonic
Procter And Gamble
PPG
Roche
Sanofi
Shell_GameChanger
siemens
solvay
Toyota.gif

In Partnership with

NSTI


Sponsorship Opportunities: Contact Denise Lee

Free Subscription

E-mail:

pbh(); ?>